• Topics

  • Formats

Speakers: Joe Gigliotti, MD, MBA & Vinayagam Arunachalam

Event Overview:

Takeda's Head of Computational & Systems Biology joins Causaly to share how AI evidence synthesis is compressing R&D timelines from indication expansion to Phase 3 decisions. Hear the real use cases, real results, and real lessons from the frontline of pharma AI adoption.

Key Learning Objectives:

  • Understand why purpose-built scientific AI outperforms general LLMs for R&D
  • Gain insight from real use cases: indication expansion, MoA analysis, Phase 3 support
  • Know how to scale AI adoption from early pilots to team-wide practice

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?